Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 256

1.

[Clinicopathological characteristics and prognosis of uterine malignant mixed Mullerian tumor].

Zhu AN, Guan MF, Zhu Y, Li Y, Zhou L, Li CZ, Huang P.

Nan Fang Yi Ke Da Xue Xue Bao. 2016 Aug 20;36(9):1299-1302. Chinese.

PMID:
27687669
2.

Ovarian carcinosarcoma: a case report, diagnosis, treatment and literature review.

Makris GM, Siristatidis C, Battista MJ, Chrelias C.

Hippokratia. 2015 Jul-Sep;19(3):256-9.

3.

Primary malignant mixed Müllerian tumour (MMMT) of the vagina and review of the literature.

Visvalingam G, Lee WK, Wong CF, Lim YK.

BMJ Case Rep. 2016 Apr 25;2016. pii: bcr2016214856. doi: 10.1136/bcr-2016-214856. Review.

PMID:
27113789
4.

[Extragenital malignant Müllerian carcinosarcoma with invasion of inferior vena cava - a case report].

Moláček J, Brůha J, Baxa J, Opatrný V, Třeška V.

Rozhl Chir. 2016 Jan;95(1):45-7. Czech.

PMID:
26982192
5.

Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor.

Hale D, Senem DA, Ovgu A, Hakan E, Sennur I, Zerrin C, Fuat D.

Case Rep Obstet Gynecol. 2015;2015:612824. doi: 10.1155/2015/612824.

6.

[Diagnostic of uterine sarcoma, review of 11 cases].

Cárdenas-Serrano ÓE, Villalón-López JS, Ruiz-Mar G, Daza-Benítez L.

Ginecol Obstet Mex. 2015 Sep;83(9):515-21. Spanish.

PMID:
26591039
7.

Uterine carcinosarcoma/malignant mixed Müllerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy.

Wilson BT, Cordell HJ.

J Gynecol Oncol. 2015 Oct;26(4):249-51. doi: 10.3802/jgo.2015.26.4.249. No abstract available.

8.

Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.

Pires ES, D'Souza RS, Needham MA, Herr AK, Jazaeri AA, Li H, Stoler MH, Anderson-Knapp KL, Thomas T, Mandal A, Gougeon A, Flickinger CJ, Bruns DE, Pollok BA, Herr JC.

Oncotarget. 2015 Oct 6;6(30):30194-211. doi: 10.18632/oncotarget.4734.

9.

Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.

Gupta M, Kiruthiga KG.

BMJ Case Rep. 2015 Jun 29;2015. pii: bcr2015209981. doi: 10.1136/bcr-2015-209981.

PMID:
26123463
10.

[Metastatic collision tumour. A case report].

Rosas-Guerra OZ, Pérez-Castro y Vázquez JA, Andrade-López GH, Vera-Rodríguez F, Garza-de la Llave H.

Cir Cir. 2015 May-Jun;83(3):238-42. doi: 10.1016/j.circir.2015.05.008. Spanish.

11.

Ovarian carcinosarcoma in a renal transplant recipient. A unique case of a rare tumor.

Vernadakis S, Moris D, Delimpalta C, Bokos J, Zavos G.

Hippokratia. 2014 Oct-Dec;18(4):364-5.

12.

Carcinosarcoma of the uterine cervix arising from Müllerian ducts.

Kim M, Lee C, Choi H, Ko JK, Kang G, Chun KC.

Obstet Gynecol Sci. 2015 May;58(3):251-5. doi: 10.5468/ogs.2015.58.3.251.

13.

Extragenital malignant mixed Mullerian tumor in the incisional hernia - primary carcinosarcoma in the abdominal wall: case report.

Žuvela M, Micev M, Terzić M, Šaranović D, Galun D, Milićević M.

Srp Arh Celok Lek. 2015 Mar-Apr;143(3-4):199-204.

PMID:
26012132
14.

Uterine carcinosarcoma: A review of the literature.

Cantrell LA, Blank SV, Duska LR.

Gynecol Oncol. 2015 Jun;137(3):581-8. doi: 10.1016/j.ygyno.2015.03.041. Review.

PMID:
25805398
15.

Primary malignant mixed Müllerian tumour of the fallopian tube: a rare and difficult but possible diagnosis.

Vale-Fernandes E, Rodrigues F, Serrano P, Silva AI.

BMJ Case Rep. 2015 Mar 16;2015. pii: bcr2014209268. doi: 10.1136/bcr-2014-209268. No abstract available.

PMID:
25777490
16.

Prolonged survival of a patient with pelvic recurrence of ovarian malignant mixed mullerian tumor after chemoradiotherapy.

Homaei Shandiz F, Kadkhodayan S, Hsanzade Mofrad M, Yousefi Roodsari Z, Sharifi Sistani N, Nabizadeh Marvast M, Sadeghei M.

Iran Red Crescent Med J. 2014 Sep 5;16(9):e14919. doi: 10.5812/ircmj.14919.

17.

Primary malignant mixed Müllerian tumor of the fallopian tube after subtotal hysterectomy: a case report and literature review.

Ji J, Zuo P, Li L, Wang Y.

Arch Gynecol Obstet. 2015 May;291(5):1187-90. doi: 10.1007/s00404-014-3611-z. Review. No abstract available.

PMID:
25588328
18.

Review literature on uterine carcinosarcoma.

Singh R.

J Cancer Res Ther. 2014 Jul-Sep;10(3):461-8. doi: 10.4103/0973-1482.138197. Review.

19.

Synchronous malignant mixed Müllerian tumor of the uterus with transitional cell carcinoma of the ovary.

Sahai P, Kakkar A, Pathy S, Kumar L, Bhatla N, Chander S.

J Obstet Gynaecol Res. 2015 Feb;41(2):319-23. doi: 10.1111/jog.12510.

PMID:
25227514
20.

Synchronous uterine carcinosarcoma and contralateral breast cancer after tamoxifen therapy: a case report.

Shen L, Hong L, Zhang G, Mai R.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):5295-301.

Items per page

Supplemental Content

Loading ...
Support Center